ABC | Volume 110, Nº5, May 2018

Short Editorial Pastore TWA in Chagas disease Arq Bras Cardiol. 2018; 110(5):418-419 1. Rubart D, Zipes P. Mechanisms of sudden cardiac death. J Clin Invest. 2005;115(9):2305–15. 2. Fabre A, Sheppard MN. Sudden adult death syndrome and other nonischaemic causes of sudden cardiac death. Heart. 2006;92(3):316–20. 3. ThompsonPD,FranklinBA,BaladyGJ,BlairSN,CorradoN,EstesNArd,etal. Exercise and acute cardiovascular events: Placing the risks into perspective: A scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology – In collaborationwith the AmericanCollege of SportsMedicine. Circulation. 2007;115(17):2358–68. 4. Weiss JN, Karma A, Shiferaw Y, Chen PS, Garfinkel A, Chu Z. Frompulsus to pulseless: The saga of cardiac alternans. Circ Res. 2006;98(10):1244–53. 5. Hering HE. Experimentelle studien an s¨augetieren ¨uber das elektrocardiogram. Zeitschrift f ¨ur experimentelle Pathologie und Therapie. 1909;7:363–78. 6. Adam DR, Akselrod S, Cohen RJ. Estimation of ventricular vulnerability to fibrillationthroughT-wavetimeseriesanalysis.ComputCardiol.1981;8:307–10. 7. Zareba W, Piotrowicz K, McNitt S, Moss AJ, MADIT II Investigators. Implantable cardioverter-defibrillator efficacy in patients with heart failure and leftventriculardysfunction (fromtheMADIT IIPopulation).Am JCardiol. 2005;95(12):1487–91. 8. Salerno-Uriarte JA, De Ferrari GM, Klersy C, Pedretti RF, Tritto M, Sallusti L, et al.Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy—results of the ALPHA study. J Am Coll Cardiol. 2007;50(19):1896-904. 9. Exner DV, Kavanagh KM, Slawnych MP, Mitchell LB, Ramadan D, Aggarwal SG, et al. Noninvasive risk assessment early after a myocardial infarction— the REFINE study. J Am Coll Cardiol. 2007;50(24):2275–84. 10. Nieminen T, Lehtimaki T, Viik J, Lehtinen R, Nikus K, Koobi T, et al. T-wave alternans predicts mortality in a population undergoing a clinically indicated exercise test. Eur Heart J. 2007;28(19):2332–7. 11. Ikeda T, YoshinoH, Sugi K, Tanno K, ShimizuH,Watanabe J, et al. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction results of a collaborative cohort study. J Am Coll Cardiol. 2006;48(11):2268–74. 12. Bloomfield DM, Steinman RC, Namerow PB, Paredes M, Davidenko J, Kaufman ES, et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: A solution to the multicenter automatic defibrillator implantation trial (MADIT) II conundrum. Circulation. .2004;110(14):1885–9. 13. Bloomfield D, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol. 2002;13(5):502-12. 14. Hohnloser SH. T wave alternans. In: Zipes D, Jalife J, eds. Cardiac electrophysiology , 6 th ed. Philadelfia, PA: Elsevier Inc.; 2013. p.665-76. 15. Merchant FM, Armoundas AA. Role of substrate and triggers in the genesis of cardiac alternans, frommyocyte to thewhole heart: implications for therapy. Circulation. 2012;125(3):539-49. 16. HagjooM, Arya A, Sadr-Ameli MA. Microvolt T-wave alternans: a review of techniques, interpretation, utility, clinical studies and future perspectives. Int J Cardiol. 2 006;109(3):293-306. 17. Garcia EV, Pastore CA, Samesima N, Pereira Filho HG. T-wave alternans: desempenho clínico, limitações, metodologias de análise. Arq Bras Cardiol. 2011;96(3):e53-e61. 18. Smith JM, Clancy EA, Valeri CR,Ruskin JN, Cohen RJ. Electrical alternans and cardiac electrical instability. Circulation. 1988;77(1):110–21. 19. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med. 1994;330(4):235–41. 20. Nearing BD, Verrier RL. Modified moving average analysis of T-wave alternans to predict ventricular fibrillationwith high accuracy. J Appl Physiol. 2002;92(2):541–9. 21. de Oliveira Antunes M, Samesima N, Pereira Filho HG, Matsumoto AY, Pastore CA, Arteaga-Fernandez E, et al. Exercise-induced quantitative microvoltT-wavealternans inhypertrophiccardiomyopathy. JElectrocardiol. 2017;50(2):184-90. 22. Odozynski G, Dal Forno AR, Lewandowski A, Nascimento HG, d’Avila A. Ablação de fibrilação atrial paroxística emmulheres:compreendendo a diferença entre gêneros. Arq Bras Cardiol. 2018; 110(5):412-417 References This is an open-access article distributed under the terms of the Creative Commons Attribution License 419